HBSP (USA)
-
Group Functions at the Maersk Group
Collis, David J.; Shaffer, MatthewCase HBS-715432-EStrategyIn 2014, seven years after he was appointed CEO of the Danish shipping and oil conglomerate A.P. M ller Maersk (the Maersk Group), Nils Andersen was reexamining the size and role of corporate headquarters in the company he had reshaped as a "premium conglomerate." During his tenure, Andersen had divided what had previously been operated as almost a single entity into separate lines of business, each accountable for its own performance and expect...Starting at €8.20
-
Tapestry Networks
Ramanna, Karthik; Shaffer, MatthewCase HBS-114051-EAccounting and ControlTapestry Networks assembled industry leaders and their regulators in small, private meetings to build new frameworks for pressing regulatory challenges. Tapestry's motivating principle was to reimagine solutions to complex problems (e.g., drug-approval standards) in ways that created a win-win for firms and society. Tapestry meetings on bank-governance standards-initiated after the 2008-2009 Financial Crisis-had experienced some success in rebuil...Starting at €8.20
-
Fairstar Heavy Transport (A)
Subramanian, Guhan; Ghosh, RheaCase HBS-911036-ETo maximize their effectiveness, color cases should be printed in color. In 2009, the small heavy marine transport company Fairstar entered into bidding on one of the largest contracts in the history of the industry. Chronicles the company's year-long tendering process, leading up to a final make-or-break meeting.Starting at €8.20
-
Fairstar Heavy Transport (C)
Subramanian, Guhan; Ghosh, RheaCase HBS-911043-ESupplements the (A) and (B) case.Starting at €5.74
-
Remicade/Simponi: Confidential Instructions for Merck
Subramanian, Guhan; Ghosh, RheaCase HBS-911044-EThis two-party negotiation exercise features a real-life dispute between Merck and Johnson & Johnson regarding European distribution rights to two highly lucrative drugs.Starting at €8.20
-
Remicade/Simponi: Confidential Instructions for Johnson & Johnson
Subramanian, Guhan; Ghosh, RheaCase HBS-911045-EThis two-party negotiation exercise features a real-life dispute between Merck and Johnson & Johnson regarding European distribution rights to two highly lucrative drugs.Starting at €8.20
-
Remicade/Simponi, Teaching Plan
Subramanian, Guhan; Krontiris, CharlotteTeaching Note HBS-914006-ETeaching Plan for 911044, 911045, and 911046. This exercise models a negotiation between two pharmaceutical companies-Johnson & Johnson and Merck-concerning the international distribution rights for Remicade, a blockbuster anti-arthritis drug. At odds over the original distribution contract, the two companies enter a final negotiation session before they must take their case to arbitration. This exercise gives students the opportunity to experim...Starting at €0.00
-
Lazard LLC
Subramanian, Guhan; Sherman, EliotCase HBS-907046-ELeadership and People ManagementDescribes Lazard's situation in 2001, and supplies context for the subsequent negotiation between its Chairman and his hand-picked successor. In 2001 Lazard, the last of the great investment houses to remain both private and in the control of its founding family, is in a state of decline. Infighting throughout the 1990s led to a defection of talent that left many wondering if Lazard could compete with the diversified financial behemoths of the 21...Starting at €8.20
-
Fairstar Heavy Transport (B)
Subramanian, Guhan; Ghosh, RheaCase HBS-911042-ESupplements the (A) case.Starting at €5.74
-
Remicade/Simponi: Legal Memorandum
Subramanian, Guhan; Ghosh, RheaCase HBS-911046-ESupplements Remicade/Simponi: Confidential Instructions for Johnson & Johnson and Remicade/Simponi: Confidential Instructions for Merck.Starting at €8.20